JPWO2022098846A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022098846A5 JPWO2022098846A5 JP2023528093A JP2023528093A JPWO2022098846A5 JP WO2022098846 A5 JPWO2022098846 A5 JP WO2022098846A5 JP 2023528093 A JP2023528093 A JP 2023528093A JP 2023528093 A JP2023528093 A JP 2023528093A JP WO2022098846 A5 JPWO2022098846 A5 JP WO2022098846A5
- Authority
- JP
- Japan
- Prior art keywords
- vista
- agonist
- antibody
- optionally
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109584P | 2020-11-04 | 2020-11-04 | |
| US63/109,584 | 2020-11-04 | ||
| PCT/US2021/058020 WO2022098846A1 (en) | 2020-11-04 | 2021-11-04 | Vista agonist for treatment/prevention of ischemic and/or reperfusion injury |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023550310A JP2023550310A (ja) | 2023-12-01 |
| JPWO2022098846A5 true JPWO2022098846A5 (https=) | 2024-11-07 |
| JP2023550310A5 JP2023550310A5 (https=) | 2024-11-07 |
Family
ID=81458372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528093A Pending JP2023550310A (ja) | 2020-11-04 | 2021-11-04 | 虚血及び／または再灌流障害の治療／予防のためのｖｉｓｔａアゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230399405A1 (https=) |
| EP (1) | EP4240409A4 (https=) |
| JP (1) | JP2023550310A (https=) |
| KR (1) | KR20230142828A (https=) |
| CN (1) | CN116600826A (https=) |
| AU (1) | AU2021373781A1 (https=) |
| CA (1) | CA3197359A1 (https=) |
| WO (1) | WO2022098846A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024172543A1 (ko) * | 2023-02-17 | 2024-08-22 | 뉴패스바이오(주) | Igsf11-fc 융합 단백질 또는 이를 암호화하는 폴리뉴클레오티드를 포함하는 자가면역질환 또는 염증성 질환의 예방 또는 치료용 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3421486T5 (da) * | 2012-06-22 | 2024-09-16 | The Trustees Of Darthmouth College | Nye Vista-IG-konstruktioner og anvendelse af Vista-IG til behandling af autoimmune, allergiske og inflammatoriske lidelser |
| JP6368308B2 (ja) * | 2012-09-07 | 2018-08-01 | トラスティーズ・オブ・ダートマス・カレッジ | 癌の診断および治療のためのｖｉｓｔａ調節剤 |
| MX2015007446A (es) * | 2012-12-12 | 2015-12-07 | Vasculox Inc | Anticuerpos terapeuticos para cd47. |
| WO2017181109A1 (en) * | 2016-04-15 | 2017-10-19 | Michael Molloy | Anti-human vista antibodies and use thereof |
| CN109789201B (zh) * | 2016-04-15 | 2023-06-16 | 伊穆奈克斯特股份有限公司 | 抗人vista抗体及其用途 |
-
2021
- 2021-11-04 AU AU2021373781A patent/AU2021373781A1/en active Pending
- 2021-11-04 JP JP2023528093A patent/JP2023550310A/ja active Pending
- 2021-11-04 EP EP21890045.4A patent/EP4240409A4/en not_active Withdrawn
- 2021-11-04 CN CN202180084646.0A patent/CN116600826A/zh active Pending
- 2021-11-04 KR KR1020237018789A patent/KR20230142828A/ko active Pending
- 2021-11-04 US US18/035,399 patent/US20230399405A1/en active Pending
- 2021-11-04 CA CA3197359A patent/CA3197359A1/en active Pending
- 2021-11-04 WO PCT/US2021/058020 patent/WO2022098846A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100562339C (zh) | 小儿慢性关节炎相关疾病治疗剂 | |
| AU2008208321B2 (en) | Chronic rejection inhibitor | |
| AU2006300234B2 (en) | Agents for suppressing damage to transplanted islets after islet transplantation | |
| CN111068062B (zh) | 治疗白介素-6相关疾病的方法 | |
| CN1893979B (zh) | 血管炎治疗剂 | |
| WO2002036164A1 (en) | Blooe vegf level-lowering agent containing il-6 antagonist as the active ingredient | |
| JP2021526534A5 (https=) | ||
| WO2000010607A1 (en) | Preventives or remedies for pancreatitis containing il-6 antagonists as the active ingredient | |
| CN112105387A (zh) | 特应性皮炎的治疗 | |
| WO2015198146A2 (en) | Anti-il4-il 13 bispecific antibodies | |
| JPWO2022098846A5 (https=) | ||
| EP3371218A1 (en) | Treatment paradigm | |
| ZA200608884B (en) | Methods of treating autoimmune and inflammatory diseases | |
| KR20230142834A (ko) | 항-cd38 항체 및 이의 용도 | |
| AU756167B2 (en) | Application of TNF antagonists as medicaments for treating septic diseases | |
| JPWO2020154626A5 (https=) | ||
| JP2023550310A (ja) | 虚血及び／または再灌流障害の治療／予防のためのｖｉｓｔａアゴニスト | |
| US20020006405A1 (en) | Sepsis remedy comprising anti-il-8 antibody as active ingredient | |
| WO2024036385A1 (en) | Treatment of myocarditis by administration of anti-interleukin-6 antibodies | |
| US20210017278A1 (en) | Treatment and Prophylaxis of Amyloidosis | |
| JPWO2022036151A5 (https=) | ||
| HK40019620A (en) | Methods for treating interleukin-6 related diseases | |
| HK40019620B (en) | Methods for treating interleukin-6 related diseases | |
| RU2024117500A (ru) | Дозы и введение антител против c5 для лечения атипичного гемолитико-уремического синдрома (агус) | |
| Spearman | Orthotopic liver transplantation at Groote Schuur Hospital: a serial analysis of biliary cytokines and biochemical parameters |